Scanadu, established in 2011, is a digital health technology platform that aims to empower personal health with next-generation diagnostics, devices, and insights. The company's focus lies in creating advanced tests, devices, and services designed to help individuals monitor and better understand their personal health. The recent Series B investment of $35.00M on 27 April 2015 included prominent investors such as AME Cloud Ventures, iGlobe Partners, HIGHLINE vc, Fosun International, CBC Capital, Tencent, and BioVenture. With a strong emphasis on health care, medical devices, and mobile industries, Scanadu is in a prime position to make waves in the health tech sector.
No recent news or press coverage available for Scanadu.